We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Roche Products (Ireland) Ltd

3004 Lake Drive, Citywest, Naas Road, Dublin 24,
Telephone: +353 1 469 0700
Fax: +353 1 469 0791
Medical Information e-mail: ireland.druginfo@roche.com
Patient Information Leaflet last updated on medicines.ie: 13/11/2017
PIL Cymevene 500mg Powder for Concentrate for Solution for Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13/11/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision
Updated on 17/11/2016 and displayed until 13/11/2017
Reasons for adding or updating:
  • Change to section 6 - date of revision
  • Change to other sources of information section
  • Correction of spelling/typing errors
Updated on 17/05/2016 and displayed until 17/11/2016
Reasons for adding or updating:
  • Change due to harmonisation of PIL
Updated on 30/09/2015 and displayed until 17/05/2016
Reasons for adding or updating:
  • Change to date of revision
  • Addition of information on reporting a side effect.
Updated on 14/04/2011 and displayed until 30/09/2015
Reasons for adding or updating:
  • Change to further information section
Updated on 10/12/2010 and displayed until 14/04/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to further information section
Updated on 26/08/2008 and displayed until 10/12/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 20/10/2005 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change to marketing authorisation holder
  • Change to date of revision
Updated on 17/05/2005 and displayed until 20/10/2005
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Ganciclovir Sodium